Image Solutions Inc. (ISI), a leading provider of electronic submissions management and publishing solutions for the life sciences industry, has unveiled a prestigious line-up of speakers for its annual eSolutions Conference in Barcelona, Spain, this September to support an agenda aimed at reinventing the regulatory function.
The ISI eSolutions Conference, now in its seventh year, takes place on 29-30 September, at the Spanish city’s Hotel Arts, following the theme, “Accelerating Change in the New R&D Paradigm”.
The annual event is one of the most recognised dates in the calendar for senior-level pharmaceutical executives looking to share ideas with peers, build partnerships with industry thought leaders, and hear from key experts on how they are addressing some of their most pressing challenges.
Those attending in Barcelona this September can look forward to an informative programme, with a keynote address from Dr. Carlos Buesa, Chief Executive Officer of Oryzon Genomics, one of the fastest-growing biotech companies in Spain. Dr. Buesa also serves as vice president of the Spanish biotechnology association, ASEBIO, president of the Association of Catalan Biotechnology Companies (CataloniaBio), and he is a member of the governing body of the Executive Committee of BioRegió de Catalunya, a new regional development model aimed at improving the biotechnology cluster in Catalonia. Dr. Buesa also sits on the boards of other leading biotech companies.
Dr. Buesa got his PhD in Biochemistry from the University of Barcelona, Spain. He has produced more than thirty papers and patents. He developed most of his scientific career in the Pharmacy Faculty at the University of Barcelona. After his PhD, he was awarded an EU post-doctoral fellowship with the Faculty of Medicine at the University of Ghent in Belgium where later he became Senior Investigator with the Flemish Institute of Biotechnology (VIB).
The programme will also provide a forum for a series of candid insights from the coalface, with case studies and presentations from high-profile executives, including:
- David Licht, Senior Director of Global Regulatory & Safety Operations, Allergan
- Meredith Purcell, Associate Director, Global Regulatory Publishing, Allergan
- Ulf Klingnäs, Submission Manager, AstraZeneca
- Craig Funt, Executive Director, Acquisition, Collaboration and Information Services, Bristol-Myers Squibb
- María Pascual, Director of Regulatory Affairs, Cellerix
- Todd Gerig, Technology Integrator, Eli Lilly
- Vicki Phelan, Pharmaceutical Managing Director, EquaTerra
- Stephen Hasler, VP, Regulatory Operations, GlaxoSmithKline
- Bill Snyder, Director, Information and Records Management, Pfizer
- Dr. Geoffrey Williams, e-Regulatory Liaison, Roche
- Graham Shelvey, Senior Director Worldwide Regulatory Operations, Sanofi-Aventis
- Joel Alvarez, Associate Director, Global Regulatory Operations, Shire HGT Inc.
- Tracy Baldwin, EU Regulatory Operations, Takeda
- Janis Gyzen, Assistant Director Submission Programs, Takeda
- Rick Lilley, VP, Global Regulatory Affairs at UCB Pharma
- Dr. Chang Woo Suh, Daewoong Pharmaceutical Co. Ltd., Korea
- Hans van Bruggen, MSc., eCTDconsultancy B.V.
Why Attend?